-
1
-
-
0033610715
-
Treatment of traumatic bleeding with recombinant factor VIIa
-
Kenet G, Walden R, Eldad A, Martinowitz U: Treatment of traumatic bleeding with recombinant factor VIIa. Lancet 1999; 354: 1879.
-
(1999)
Lancet
, vol.354
, pp. 1879
-
-
Kenet, G.1
Walden, R.2
Eldad, A.3
Martinowitz, U.4
-
2
-
-
0002559575
-
The use of recombinant factor VIIa in controlling surgical bleeding in non-haemophiliac patients
-
Aldouri M: The use of recombinant factor VIIa in controlling surgical bleeding in non-haemophiliac patients: pathophysiology of haemostasis and thrombosis 2002; 32(Suppl 1): 41-6.
-
(2002)
pathophysiology of haemostasis and thrombosis
, vol.32
, Issue.SUPPL. 1
, pp. 41-46
-
-
Aldouri, M.1
-
3
-
-
24644491444
-
-
Boffard KD, Riou B, Warren B, et al: Recombinant factor VIIa as adjunctive therapy for bleeding control in severely injured trauma patients: two parallel randomized, placebo-controlled, double-blind clinical trials. J Trauma 2005; 59: 8-15; discussion 8.
-
Boffard KD, Riou B, Warren B, et al: Recombinant factor VIIa as adjunctive therapy for bleeding control in severely injured trauma patients: two parallel randomized, placebo-controlled, double-blind clinical trials. J Trauma 2005; 59: 8-15; discussion 8.
-
-
-
-
4
-
-
0037612571
-
Recombinant factor VIIa for control of hemorrhage: Early experience in critically ill trauma patients
-
Dutton RP, Hess JR, Scalea TM: Recombinant factor VIIa for control of hemorrhage: early experience in critically ill trauma patients. J Clin Anesth 2003; 15: 184-8.
-
(2003)
J Clin Anesth
, vol.15
, pp. 184-188
-
-
Dutton, R.P.1
Hess, J.R.2
Scalea, T.M.3
-
5
-
-
21244463146
-
Emerging off-label uses for recombinant activated factor VII: Grading the evidence
-
Enomoto TM, Thorborg P: Emerging off-label uses for recombinant activated factor VII: grading the evidence. Crit Care Clinics 2005; 21: 611-32.
-
(2005)
Crit Care Clinics
, vol.21
, pp. 611-632
-
-
Enomoto, T.M.1
Thorborg, P.2
-
6
-
-
19944433743
-
Recombinant coagulation factor VIIa in major liver resection: A randomized, placebo-controlled, double-blind clinical trial
-
Lodge JP, Jonas S, Oussoultzoglou E, et al: Recombinant coagulation factor VIIa in major liver resection: a randomized, placebo-controlled, double-blind clinical trial. Anesthesiology 2005; 102: 269-75.
-
(2005)
Anesthesiology
, vol.102
, pp. 269-275
-
-
Lodge, J.P.1
Jonas, S.2
Oussoultzoglou, E.3
-
7
-
-
31744451276
-
Recombinant activated factor VIIa and hemostasis in critical care: A focus on trauma
-
Mohr AM, Holcomb JB, Dutton RP, Duranteau J: Recombinant activated factor VIIa and hemostasis in critical care: a focus on trauma. Crit Care (London) 2005; 9 Suppl 5: S37-42.
-
(2005)
Crit Care (London)
, vol.9
, Issue.SUPPL. 5
-
-
Mohr, A.M.1
Holcomb, J.B.2
Dutton, R.P.3
Duranteau, J.4
-
8
-
-
10244244936
-
Uses of recombinant factor VIIa in trauma
-
Stein DM, Dutton RP: Uses of recombinant factor VIIa in trauma. Curr Opin Crit Care 2004; 10: 520-8.
-
(2004)
Curr Opin Crit Care
, vol.10
, pp. 520-528
-
-
Stein, D.M.1
Dutton, R.P.2
-
9
-
-
34247551016
-
Recommendations on the use of recombinant activated factor VII as an adjunctive treatment for massive bleeding: A European perspective
-
Vincent JL, Rossaint R, Riou B, et al: Recommendations on the use of recombinant activated factor VII as an adjunctive treatment for massive bleeding: a European perspective. Crit Care (London) 2006; 10: R120.
-
(2006)
Crit Care (London)
, vol.10
-
-
Vincent, J.L.1
Rossaint, R.2
Riou, B.3
-
10
-
-
33744983991
-
Introduction to military medicine: A brief overview
-
Hetz SP: Introduction to military medicine: a brief overview. Surg Clinics North Am 2006; 86: 675-88.
-
(2006)
Surg Clinics North Am
, vol.86
, pp. 675-688
-
-
Hetz, S.P.1
-
11
-
-
33744986997
-
Special lessons learned from Iraq
-
Sebesta J: Special lessons learned from Iraq. Surg Clinics North Am 2006; 86: 711-26.
-
(2006)
Surg Clinics North Am
, vol.86
, pp. 711-726
-
-
Sebesta, J.1
-
12
-
-
23044495075
-
Emergency war surgery
-
Borden Institute:, Washington, DC, Department of Defense
-
Borden Institute: Emergency war surgery. Third U.S. revision. Washington, DC, Department of Defense, 2004.
-
(2004)
Third U.S. revision
-
-
-
14
-
-
33644824521
-
Predictors of mortality in close proximity blast injuries during Operation Iraqi Freedom
-
Nelson TJ, Wall DB, Stedje-Larsen ET, et al: Predictors of mortality in close proximity blast injuries during Operation Iraqi Freedom. J Am Coll Surg 2006; 202: 418-22.
-
(2006)
J Am Coll Surg
, vol.202
, pp. 418-422
-
-
Nelson, T.J.1
Wall, D.B.2
Stedje-Larsen, E.T.3
-
16
-
-
0030292504
-
Orr Memorial Lecture: Staged laparotomy for the hypothermia, acidosis, and coagulopathy syndrome
-
Moore EE, Thomas G: Orr Memorial Lecture: staged laparotomy for the hypothermia, acidosis, and coagulopathy syndrome. Am J Surg 1996; 172: 405-10.
-
(1996)
Am J Surg
, vol.172
, pp. 405-410
-
-
Moore, E.E.1
Thomas, G.2
-
17
-
-
44649112504
-
Use of rFVIIa in the trauma setting - practice patterns in United States trauma centers
-
Horton JD, DeZee KJ, Wagner M: Use of rFVIIa in the trauma setting - practice patterns in United States trauma centers. Am Surgeon 2008; 74: 413-7.
-
(2008)
Am Surgeon
, vol.74
, pp. 413-417
-
-
Horton, J.D.1
DeZee, K.J.2
Wagner, M.3
-
18
-
-
24644498683
-
Low-dose recombinant activated factor VII results in less blood and blood product use in traumatic hemorrhage
-
Harrison TD, Laskosky J, Jazaeri O, Pasquale MD, Cipolle M: "Low-dose" recombinant activated factor VII results in less blood and blood product use in traumatic hemorrhage. J Trauma 2005; 59: 150-4.
-
(2005)
J Trauma
, vol.59
, pp. 150-154
-
-
Harrison, T.D.1
Laskosky, J.2
Jazaeri, O.3
Pasquale, M.D.4
Cipolle, M.5
-
19
-
-
47649107932
-
Part 1 of 3: Dangerous remedy
-
November 19
-
Little R: Part 1 of 3: Dangerous remedy. Baltimore Sun, November 19, 2006.
-
(2006)
Baltimore Sun
-
-
Little, R.1
-
20
-
-
47649099518
-
Part 2 of 3: Don't let me die
-
November 20
-
Little R: Part 2 of 3: "Don't let me die." Baltimore Sun, November 20, 2006.
-
(2006)
Baltimore Sun
-
-
Little, R.1
-
21
-
-
47649093487
-
Part 3 of 3: Dubious breakthrough
-
November 21
-
Little R: Part 3 of 3: Dubious breakthrough. Baltimore Sun, November 21, 2006.
-
(2006)
Baltimore Sun
-
-
Little, R.1
-
22
-
-
34147161076
-
Thromboembolic complications associated with factor VIIa administration
-
Thomas GO, Dutton RP, Hemlock B, et al: Thromboembolic complications associated with factor VIIa administration. J Trauma 2007; 62: 564-9.
-
(2007)
J Trauma
, vol.62
, pp. 564-569
-
-
Thomas, G.O.1
Dutton, R.P.2
Hemlock, B.3
-
23
-
-
43149120223
-
The effect of recombinant activated factor VII on mortality in combat-related casualties with severe trauma and massive transfusion
-
discussion 93-4
-
Spinella PC, Perkins JG, McLaughlin DF, et al: The effect of recombinant activated factor VII on mortality in combat-related casualties with severe trauma and massive transfusion. J Trauma 2008; 64: 286-93; discussion 93-4.
-
(2008)
J Trauma
, vol.64
, pp. 286-293
-
-
Spinella, P.C.1
Perkins, J.G.2
McLaughlin, D.F.3
|